Home/Avery Therapeutics/Ronnda Bartel, PhD
RB

Ronnda Bartel, PhD

Chief Medical Officer

Avery Therapeutics

Avery Therapeutics Pipeline

DrugIndicationPhase
MyCardia™Heart FailurePre-clinical